BioWorld MedTech

Aug. 15, 2016

Foreign devices excluded from China's new expedited review for high-priority med tech

Over the summer the CFDA proposed a new expedited review program for high-priority devices, but it excludes foreign devices from participation, to the chagrin of industry players around the world. Read More

Boy-shaped robot equipped to assess dementia patients

FDA panel to eye OTC tests for viral pathogens

Country aims to boost trade ties with Southeast Asia

Other news to note

Appointments and advancements

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...